Fresenius Medical Care plans to sell select assets of Spectra Laboratories to Quest Diagnostics as it exits non-core markets.

Quest Diagnostics Inc. DGX benefits from its robust utilization of the Advanced Diagnostics portfolio offerings. The company also expands through strategic acquisitions, completing eight transactions ...

The acquisition will add dialysis-related water testing to Quest’s portfolio and position the company to perform the tests ...

Fresenius Medical Care announced today that it agreed to sell select assets of its laboratory testing services to Quest ...

Quest Diagnostics Incorporated (DGX), headquartered in Secaucus, New Jersey, offers diagnostic testing and services globally.

Fresenius Medical Care (XETRA: FME; NYSE: FMS), the world's leading provider of products and services for individuals with ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, recently announced that it has been selected as one of the 2025 World's Most Admired Companies™ by Fortune® ...

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine ...

Hims & Hers is expanding its offerings through the Trybe Labs deal after it added compounded weight loss drugs.

GRAIL's Galleri Test Now Directly Available to Physicians in the U.S. Through Collaboration With Quest Diagnostics, Delivering a More Streamlined Provider and Patient Experience MENLO PARK ...

Grail (GRAL) and Quest Diagnostics (DGX) announced the initial phase of a program to improve provider access to GRAIL’s Galleri multi-cancer ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, and Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, ...